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OCCIPITAL WHITE MATTER VOLUMES PREDICT VISUAL MOTOR OUTCOME 
IN PRETERM INFANTS WITH RETINOPATHY OF PREMATURITY (ROP).  
Chundru, Renu, Vohr, Betty, Kesler, Shelli, and Ment, Laura R.  Section of Neurology, 
Department of Pediatrics, Yale University, School of Medicine, New Haven, CT. 
 
Although very low birth weight preterm (VLBW) infants with grade 3,4 
retinopathy of prematurity (ROP) are at high risk for unfavorable visual outcomes, the 
middle school vision motor integration (VMI) skills and cognitive outcome scores of 
these children remain largely unknown.  Data for 323 very VLBW survivors of the 
Multicenter Randomized Indomethacin IVH Prevention Trial (BW 600 – 1250 g) were 
analyzed to test the hypothesis that grades 3, 4 ROP would be an important predictor of 
cognitive and VMI skills.  3 subgroups were evaluated: ROP negative (N = 163), ROP 
grades 1,2 (N = 137) and ROP grades 3,4 (N = 23) were evaluated prospectively at 12 
years of age with a neurocognitive battery.  High-resolution volumetric MRI scans were 
quantified for 40 of the study subjects, and occipital  brain volumes were correlated with 
Beery VMI scores.  Children with ROP 3-4 had ↑ vision impairment and lower test 
scores.  Whole brain volumes were significantly less for children with any grade of ROP 
(p = 0.02), occipital white matter volumes tended to be less for the same study subjects (p 
= 0.08) and both total occipital brain volumes and occipital white matter volumes were 
significantly correlated with Beery VMI scores (r=0.610, p = 0.009 and r = 0.652, p 
=0.005, respectively).  Prematurely-born children with a history of grade 3-4 ROP 
continue to have ↑ vision impairment, special needs and lower performance on cognitive, 
language and visual motor integration scores at age 12 years.  Both whole occipital brain 
volumes and occipital white matter volumes were predictive of VMI scores for children 
with ROP. (supp by NS 27116) 
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Objective:  Data for 323 very VLBW survivors of the Multicenter Randomized 
Indomethacin IVH Prevention Trial (BW 600 – 1250 g) were analyzed to test four 
hypotheses: 
 
(1.) There exist many risk factors for retinopathy of prematurity. 
(2.) Grades 3, 4 ROP are important predictors of negative visual sequelae. 
(3.) Grades 3, 4 ROP are important predictors of cognitive and VMI skills. 










































Retinopathy of prematurity (ROP) is the leading cause of childhood blindness in 
the United States (7) and has been estimated to cause visual loss in 1300 children and 
severe visual impairment in 500 children each year in the United States (47).  
Retinopathy of prematurity was first described in 1942 as a proliferative retinopathy 
which affects premature infants of low birth weight and young gestational age.  It has 
been found that up to 30% of very low birth weight infants will develop severe 
retinopathy of prematurity and 8% will progress to blindness (7).  In infants <1251 
grams, the incidence of retinopathy of prematurity was found to be a staggering 68% 
(41).  The findings of the previous study were compared to those of infants born in 
1986/1987 in the CRYO-ROP Study and it was found that the overall incidence of 
retinopathy of prematurity is similar in both studies.  In addition, the gestational age of 
onset, rate of progression and the time of onset of prethreshold disease has changed very 
little since the CRYO-ROP study which was performed years ago (41).  
During normal retinal development, vessels migrate from the optic disc to the ora 
serrata (the area at which the choroid and retina end) at around 16 weeks of gestation.  By 
36 weeks of gestation, mature vessels differentiate from these vessels and extend to the 
nasal side, and by 39-41 weeks these vessels extend temporally (50).  The fundamental 
process underlying the development of retinopathy of prematurity is the incomplete 
vascularization of the retina (1).  The location of the interruption of normal vaculogenesis 
is determined by the time of premature birth.  The abnormal neovascularization of 
retinopathy of prematurity is believed to be a result of hypoxia (1).  There has been a 
plethora of angiogenic factors which are believed to be released after tissue hypoxia, 
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including basic fibroblast growth factor (bFGF), transforming growth factor–α (TGF-α), 
and tumor necrosis factor–α (TNF-α) and which are believed to play a role in retinopathy 
of prematurity.  However, some of the greatest attention has been focused on the vascular 
endothelial growth factor (VEGF), which is found to be elevated in patients with many 
proliferative retinopathies, including retinopathy of prematurity (50).  VEGF is an 
angiogenic factor which is specific to endothelial cells and its production is increased by 
hypoxia and is believed to play a major part in mediating active intraocular 
neovascularization in patients with ischemic retinal diseases (51).  VEGF is believed to 
be induced by retinal ischemia, diffusible, more concentrated in vitreous than in the 
aqueous humor, increased during active proliferation, reduced during quiescent 
proliferation, and diminished after successful laser therapy (51). 
It has been found that in ocular tissue the production of VEGF is induced by 
hypoxia in retinal pigment epithelial cells (49).  One study which examined VEGF 
concentration in various retinal diseases found that VEGF stimulated the growth of retinal 
endothelial cells in vitro, as did vitreous fluid containing measurable VEGF.  The 
stimulation of the growth of retinal endothelial cells was inhibited by VEGF-neutralizing 
antibodies (51). 
In this same study, the VEGF concentrations in samples of aqueous and vitreous 
humor from patients with neovascular disorders were compared with those in samples 
from patients without neovascularization.  VEGF was detectable in more patients with 
revascularization, and the concentration of VEGF in these patients was very high (51).  In 
addition, this study found that the concentration of VEGF declined in all patients who had 
decreased neovascular activity after laser photocoagulation.  It is believed that it is the 
 7
reduction in retinal ischemia after laser therapy that reduces the production of angiogenic 
factors and suppresses neovascularization (51). 
Of course, as previously discussed, it is believed that VEGF solely is not 
responsible for the neovascularization that occurs during retinopathy of prematurity, but 
also involves other proliferative factors and their interaction with VEGF, including basic 
fibroblast growth factor, insulin-like growth factors, and pigment-epithelium derived 
factor (PEDF). 
In a different study, the relationship between IGF-1 and VEGF was examined.  It 
was found that IGF-1 is required for VEGF activation of vascular endothelial cell 
proliferation and survival pathways (39).  The IGF-1 levels were found to be deficient 
after premature birth, allowing for retinal vascular loss and subsequently retinopathy of 
prematurity (39.).  It was postulated that the restoration of IGF-1 to levels found in utero 
may possibly be used in the future for the prevention of retinopathy of prematurity (39). 
In one study cultured monkey retinal pigment epithelial (RPE) cells were exposed 
to low oxygen concentration in order to stimulate hypoxia (36).  In this study, it was 
found that the level of the pigment epithelium-derived factor (PEDF), a protein secreted 
by the retinal pigment epithelium was decreased in the RPE/choroids of the monkey cells 
(36).  PEDF is believed to act on retinal survival and angiogenesis, and both hypoxia and 
VEGF are thought to downregulate PEDF through proteolytic degradation (36).  A better 
understanding of the role of VEGF and other proliferative factors is needed in order to 
better understand and treat retinopathy of prematurity. 
Recently the role of genetic factors in the development of severe ROP has been 
studied.  In a recent study, genetic analysis was performed on sixteen children.  Missense 
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mutations (R121W and L108P) in the third exon of the ND gene were found in 4 patients 
affected by ROP (3).  These mutations were not present in 50 unrelated healthy control 
subjects, suggesting that mutations in the ND gene may play a role in the development of 
severe ROP in premature infants (3). 
In a more recent study, it was found that 2 patients in a cohort of 100 patients with 
ROP demonstrated the presence of ND mutations.  These mutations were not found in 
any of the controls.  Although the ND gene is not frequently involved in advanced ROP, 
this study demonstrates that genetic influences may play an important role in the 
development of severe ROP in some premature infants (4). 
  The classification of retinopathy of prematurity is based on several key 
observations which are essential to the description of retinopathy of prematurity (42).   
The first key observation used involves the location of retinal involvement by zone.  To 
define the location of the retinopathy, 3 concentric zones of retinal involvement have 
been defined – each zone is centered on the optic disc (42).  Because there is a direct 
correlation between severity of disease and amount of avascular retina, the location of the 
border between vascularized and avascular retina is an important prognostic sign (51).  
The second key observation used is the extent of retinal involvement recorded as 
hours of the clock or as 30 degree sectors (42).   
The third observation used is the staging of the severity of the retinopathy at the 
junction of the vascularized and avascular retina.  This classification is the most pertinent 
to our study, as we separated the three groups of premature infants based on the stage of 
severity of the retinopathy of prematurity.  5 stages are used to describe the abnormal 
vascular response at the junction of the vascularized and avascular retina.  As more than 1 
 9
stage of retinopathy of prematurity may be present in the eye, the stage of the eye is 
determined by the most severe manifestation which is present (42).  Stage 1 is considered 
the demarcation line, which is a thin line which separates the avascular retina from the 
vascularized retina.  The abnormal vessels that lead to the demarcation line are relatively 
flat and lie within the plane of the retina.  Although vascular changes can be apparent 
prior to the development of the demarcation line, such as the dilation of the peripheral 
retinal vessels, these changes are insufficient for the diagnosis of ROP (42). 
 The second stage of retinopathy of prematurity is defined as a ridge which arises 
in the area of the demarcation line, but has a height and width, extending above the plane 
of the retina.  The ridge may change from white to pink and vessels may leave the plane 
of the retina posterior to the ridge to enter it (42). 
 Stage three retinopathy of prematurity is defined by neovascularization that 
extends from the ridge into the vitreous, and can cause a ragged appearance as the 
proliferation becomes more extensive.  The severity of a stage 3 lesion can be subdivided 
into mild, moderate, or severe depending on the extent of extraretinal fibrovascular tissue 
infiltrating the vitreous (42). 
Stage four is defined by a partial retinal detachment.  This stage is divided into 
stage 4A (extrafoveal) and stage 4B (foveal) partial retinal detachments (42).  Typically, 
the retinal detachments begin at the point of the fibrovascular attachment to the 
vascularized retina (42).   
The final stage of retinopathy of prematurity is stage 5, total retinal detachment, 
which is generally tractional and may occasionally be exudative and usually funnel 
shaped, the configuration of which permits a subdivision of this stage (42). 
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The final key observation used in the classification of retinopathy of prematurity 
is the presence or absence of dilated and tortuous posterior pole vessels, which is 
significant for plus disease (42).  “Plus disease” occurs when the peripheral vascular 
shunting of blood is so overwhelming that it leads to marked venous dilation and arterial 
tortuosity in the posterior pole.  Plus disease is the hallmark of rapidly progressive ROP 
and is notated by adding a plus sign after the number of the ROP stage (51).  
 Key Classification criteria for retinopathy of prematurity: 
  
 (1) the location of retinal involvement by zone 
(2) the extent of retinal involvement by clock hour 
(3) the state or severity of retinopathy at the junction of the vascularized and 
avascular retina 
 












The first international classification of retinopathy of prematurity was published 
in 1984 (42).  Recently in 2005, an international group of pediatric ophthalmologists and 
retinal specialists modified some aspects of the International Classification of 
Retinopathy of Prematurity (ICROP) done in 1984, using recent evidence since the 
original publication (42). 
Some of the changes to the original classification include the addition of a more 
virulent form of retinopathy which is observed in the smallest babies.  In addition, an 
intermediate level of plus disease as well as a practical tool for estimating the extent of 
zone 1 was added (42). 
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As the treatment of threshold retinopathy of prematurity can lead to a better visual 
outcome in some infants, screening examinations of premature infants have become 
increasingly important.   It has been suggested that screening for ROP should be 
performed in all infants with a birth weight < 1500g, a gestational age ≤ 28 weeks, and in 
infants weighing between 1500g and 2000g with an unstable clinical course.  In most 
cases, at least two examinations should be performed.  The first examination should 
occur between 4 and 6 weeks chronological age or between the 31st and 33 weeks of 
postconceptional age, whichever occurs later and should be continued until 45 weeks of 
postmenstrual age, or the progression of retinal vascularization into zone III (5, 50).  
Infants at high risk for progression to threshold disease should be examined weekly.  
Infants with less severe disease in zone 2 or disease restricted to zone 3 should be 
examined every 2 weeks until the fundus matures (51). 
The ultimate goals in the treatment of threshold ROP is the prevention of any 
retinal detachment or scarring and optimization of visual outcome.  Treatment involves 
ablation of avascular retina by either cryotherapy or laser photocoagulation.  The laser 
has become the instrument of choice for ophthalmologists throughout the world for the 
treatment of threshold retinopathy of prematurity (2, 50).  In order to determine when 
treatment is indicated, the Multicenter Trial of Cryotherapy for Retinopathy of 
Prematurity (CRYO-ROP) sought to determine threshold ROP, the severity of ROP for 
which a given eye had an equal chance of spontaneous regression or progression to 
untoward outcome.  Threshold disease has become the accepted point at which treatment 
should begin.  Currently threshold disease is considered stage III+ ROP in zone 1 or 2 
occupying at least 5 contiguous clock hours or 8 noncontiguous clock hours of retina 
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(51).  Overall, in one study it was found that 65.8% of premature infants developed some 
degree of ROP and 6% reached threshold retinopathy of prematurity (48).  Infants with 
threshold ROP should receive peripheral ablative therapy within 72 hours of diagnosis 
(51). 
With an increasing number of premature infants being born, a more complete 
understanding of retinopathy of prematurity has become all the more important.  In this 
study we have sought to understand the risk factors for retinopathy of prematurity, as 
well as the sequelae of retinopathy of prematurity, focusing on the visual and cognitive 
outcome of the children at 12 years of age, as well as looking at the effect on the brain 
itself through MRI scans at 12 years of age. 
The various risk factors for the development of retinopathy of prematurity have 
been examined numerous times.  There has been agreement for some – a decreasing 
gestational age, decreasing birthweight, and increasing apneic episodes.  However, there 
is still some argument for the significance of other risk factors studied – including race, 
sex and surfactant use, among others.  In one study which examined 425 premature 
babies for ROP between January 1994 and December 1998 in Seoul, Korea retinopathy 
of prematurity was found in 20.7% of the premature infants examined (6).  The risk 
factors found in this study included a gestational age ≤ 28 weeks, a birthweight ≤ 1000 g, 
ventilator care for ≥ 48 hours, surfactant use, and apnea.  In addition, it was found that 
frequent apneic attacks increased the progression of pre-threshold ROP to threshold ROP 
(6). 
Likewise, another study which looked at the risk factors for retinopathy of 
prematurity found that infants who developed retinopathy of prematurity had a lower 
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gestational age, a lower birth weight, a higher number of days on oxygen/ventilator, more 
days in the ICU, a greater need for steroids, and a higher incidence of sepsis when 
compared to infants who did not develop ROP (7).  In this study the variables which were 
found to be statistically significant were age, weight, days on oxygen, days on the 
ventilator, days in the ICU, the need for certain medications (such as steroid use, 
surfactant, antibiotics, theophylline), and complications of prematurity (sepsis, seizures, 
intraventricular hemorrhage) (7).  An increased risk of retinopathy of prematurity in 
infants weighing less than 1600 g, included intraventricular hemorrhage. (52)  
In one study it was found that significant risk factors for retinopathy of 
prematurity included lower gestational age, decreased birth weight, and the number of 
erythrocyte transfusions within the first 4 weeks of life (38).   
Although there are many elements which are known to be risk factors of 
retinopathy of prematurity, there are also many risk factors of which a consensus has yet 
to be found.  There have been many studies which looked at race and the incidence of 
retinopathy of prematurity, yet no consensus has been reached on this subject.  A recent 
study which looked at Chinese, Indian, and Malay children in Singapore found no 
correlation between race and the incidence of retinopathy of prematurity (53).  In one 
study, no correlation was found between the race of the infant or the sex of the infant and 
the risk of developing retinopathy of prematurity.  A lower incidence of retinopathy of 
prematurity was found in the Hispanic patient compared to that of the non-Hispanic 
patient, but it was not statistically significant (7).  However, race was found to be 
significant in other studies on the incidence of retinopathy of prematurity.  One study 
found that African-American infants are less prone to severe outcome ROP than white 
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infants (12).  In addition, another study found that Alaskan natives developed threshold 
ROP earlier than non-natives (37).  In this study all Alaskan infants who weighed less 
than 1500 grams were examined from 1989 through 2003.  Alaskan natives had a higher 
incidence of threshold retinopathy of prematurity as compared with non-Alaskan natives, 
and were found to progress to treatment at a younger age.  69% of Alaskan native males 
had threshold ROP (69%), compared with 51% of non-Alaskan native males (51%).  
Although the Alaskan natives had a higher incidence of threshold retinopathy of 
prematurity, they surprisingly were found to have a greater birth weight and required less 
time on ventilation, both of which are believed to be independent risk factors for 
retinopathy of prematurity (37). 
The possible implication that gender may have on the incidence of retinopathy of 
prematurity is still unknown.  Two studies have reported that twice the number of male 
infants are affected with retinopathy of prematurity (53,54).  In one study it was 
suggested that there was an increased risk of cryotherapy in boys (10). 
Another possible risk factor of retinopathy of prematurity is indomethacin use.   
Indomethacin is a nonsteroidal anti-inflammatory agent which acts by inhibiting 
prostaglandin production.  It is thought that indomethacin may improve retinopathy when 
administered during a period of hyperoxia injury because of its effect on prostaglandin 
synthesis and consequently on retinal neovascularization.  In a mouse model, the use of 
indomethacin given concurrently with oxygen administration showed an improvement in 
oxygen induced retinopathy, but showed no effect when indomethacin was given without 
supplemental oxygen (8). 
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The effect that surfactant therapy has had on the incidence of retinopathy of 
prematurity has been examined in previous studies.  One study examined the effects of 
surfactant replacement therapy, high-frequency oscillatory ventilation (HFOV), and the 
general improvement in quality of care on the incidence of severe retinopathy of 
prematurity.  It found that of all these recent developments in neonatology only surfactant 
replacement therapy was associated with a decreased risk for severe retinopathy of 
prematurity (12). 
 The effect that postnatal steroids have on the incidence of retinopathy of 
prematurity has yet to be determined.  One study found that infants treated with 
prolonged, (greater than 24 days) of dexamethasone therapy had a significantly reduced 
incidence of cryotherapy when compared with those treated for a shorter period of time 
(10). 
However, in another study the use of post-natal steroids was found to be a risk 
factor for retinopathy of prematurity.  In one study, of 21 different factors examined only 
the use of steroids for lung disease was associated with the need for cryotherapy (11). 
It has been postulated that preeclampsia or eclampsia may reduce the incidence of 
retinopathy of prematurity, since the resulting hypertension results in intrauterine stress 
and possibly subsequent maturation of the eyes.  In one study it was found that maternal 
pre-eclampsia leads to a more favorable outcome for premature infants (12), but more 
studies are needed to confirm the possible effect that preeclampsia, and/or eclampsia may 
have on the incidence of retinopathy of prematurity. 
Although substance abuse during pregnancy has multiple negative effects on the 
infant, it does not seem to have any affect on the incidence of retinopathy of prematurity.  
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Multiple studies have found no correlation between substance abuse and the incidence of 
retinopathy of prematurity.  In one study no relationship was found between ROP and 
maternal smoking, alcohol intake, or even prenatal care (12).  Similarly in another study, 
IV drug abuse, alcohol abuse, and no prenatal care were not found to be statistically 
significant predictors of ROP (7).  
In the past hyperglycemia has been found to be a risk factor for the incidence of 
retinopathy of prematurity (46).  An increased risk of retinopathy of prematurity was 
correlated with each 10 mg/dl increase of mean glucose (46) but further studies are 
needed to make any generalized conclusions. 
Dopamine has also been examined as a possible risk factor for retinopathy of 
prematurity.  In one study it was found that dopamine use may be an indicator for the  
development of prethreshold and threshold retinopathy of prematurity.  18/41 infants 
were treated with dopamine for hypotension.  It was found that a higher percentage of the 
dopamine treated infants reached prethreshold retinopathy of prematurity and threshold 
retinopathy of prematurity.  In the dopamine treated group 67% of infants reached 
prethreshold retinopathy of prematurity and 39% reached threshold retinopathy of 
prematurity.  Comparatively, in the non-dopamine treated group only 13% reached 
prethreshold retinopathy of prematurity, and only 4% reached threshold retinopathy of 
prematurity (13).  In another study, it was found that an increased risk of retinopathy of 
prematurity was correlated with a history of dopamine infusion (52).  
One study which examined the use of vitamin E supplementation in the 
prevention of morbidity and mortality in preterm infants found that in very low birth 
weight infants, vitamin E supplementation increased the risk of sepsis, and reduced the 
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risk of severe retinopathy and blindness among those examined (14).  In another study it 
was found that a decreased risk of retinopathy of prematurity was correlated with each 
IU/kg/day of vitamin E supplementation (46). 
Although there has been great strides in understanding the various risk factors of 
retinopathy of prematurity, we are still far from being able to understand the interplay 
and importance that each risk factor ultimately has on the incidence of retinopathy of 
prematurity.  For example, although there has been a decrease in the gestational age and 
birthweight in recent years, there has also been a decrease in the incidence of retinopathy 
of prematurity.  One study found that between the years 1989 and 1998, despite there 
being a decrease in the mean gestational age and birthweight there was also a significant 
reduction in the incidence of retinopathy of prematurity (1).  The reduced incidence of 
retinopathy of prematurity was attributed to improvements in ventilation techniques and 
the overall care of the neonate, in particular the use of prenatal steroids and surfactant (1), 
thereby demonstrating that although we may be able to demonstrate the effect that 
various risk factors may have on the incidence of retinopathy of prematurity, we are still 
far from being able to determine which factors are ultimately the most important in the 
occurrence of retinopathy of prematurity in the premature infant. 
As we have previously discussed many risk factors have an effect on the 
incidence of retinopathy of prematurity.  In turn, ROP itself is believed to be a risk factor 
for negative visual and cognitive sequelae for the infant.  Prematurity on its own has long 
been seen to have a tremendous effect on the cognitive sequelae of the infants into their 
child and adulthood, and when ROP is factored in the effect is even more pronounced. 
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The relationship of cognitive sequelae to retinopathy of prematurity has been examined 
previously, but to our knowledge ours is the oldest group to be studied. 
In one study severe retinopathy of prematurity was shown to have the strongest 
association with 18-month outcome (17).  In another study it was found that among 
extremely premature infants (less than 28 weeks), with normal neonatal cranial 
ultrasounds, both serum bilirubin as well as the incidence of retinopathy of prematurity 
were associated with developmental impairment at 5 years of age.  Retinopathy of 
prematurity was associated with a poor outcome for vision, hearing, and cerebral palsy 
(15).  Interestingly enough in this study gestational age and birth weight were not 
associated with a poorer developmental outcome (15).  
In one of the first studies in which health related quality of life was measured in 
formerly premature children with and without significant visual impairments, it was 
found that threshold ROP was associated with functional limitations in health attributes 
and reduction in health related quality of life scores at 10 years of age (16).  In this study 
the parental perspectives on the health status and the health-related quality of life was 
examined in children at 10 years of age, who had a birth weight less than 1251 g and 
participated in the multicenter cryotherapy for retinopathy of prematurity (CRYO-ROP) 
study.  Moreover it was found that among those children with threshold ROP, a greater 
reduction in health related quality of life scores were found among those children with a 
poor visual outcome as compared to those with better sight.  Overall, the highest health 
related quality of life scores were found for the group of children who did not develop 
ROP, who consequently had birth weights that were 262 g higher and gestational ages 
that were 3.3 weeks greater than those of children with retinopathy of prematurity (16). 
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It is understandable that children with threshold retinopathy of prematurity would 
have higher rates of developmental, educational, and social challenges in childhood.  In 
the CRYO-ROP Multicenter study, the educational status and special education services 
among children who had threshold retinopathy of prematurity was examined at 8 years of 
age.  In this study, 33% of children who had threshold retinopathy of prematurity had 
major disabilities and a similar number had suffered from academic and social challenges 
(18). 
Of 8-year-old children with a history of threshold ROP, there were significant 
developmental, educational, and social skill differences between those who had favorable 
versus unfavorable visual status in the better eye.  Of the children with favorable visual 
status, 52 % were at grade level in academic skills, and only around ¼ required special 
education services.  In comparison, the majority of children with unfavorable visual 
status required special education placements, had below-grade-level academic skills, and 
demonstrated social challenges involving independent play, peer interaction, and 
participation in age-related sports.  In addition, significantly higher rates of 
developmental delays/disabilities, cerebral palsy, autism, and seizure disorders occurred 
in children with unfavorable visual status compared with favorable visual status (18). 
In this study it was found that favorable visual status, favorable functional ratings at 5.5 
years, markers of higher socio-economic status (such as private health insurance), and 
non-black race were associated with significantly lower rates of both special education 
placement and below-grade-level academic performance at 8 years of age.  The factors 
associated with significantly increased risk of below-grade-level performance on 
univariate analysis included black ethnicity, male gender, early abnormal neurologic 
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status, supplemental security insurance at 5.5 years, and lack of access to a car at 5.5 
years (18). 
As retinopathy of prematurity can interfere with the normal development of the 
eye, it is not surprising that it may result in a number of negative visual outcomes.  It has 
been noted that two percent of the prematurely born children are visually impaired 
(<20/60) (19).  The incidence of refractive errors in premature infants is 4 times more 
common in 10-year olds when compared with full-term controls, 29.6% versus 7.8% 
respectively.  Astigmatism and anisometropia were more common and more severe in 
premature children.  In addition, it has been shown that those prematurely born children 
with retinopathy of prematurity who were cryotreated, had the highest incidence of 
refractive error, followed by prematurely born children without ROP, 64% versus 26.2% 
respectively (19). 
Although the incidence of refractive error in premature infants with retinopathy of 
prematurity itself is higher than controls, the stage of retinopathy of prematurity has not 
been shown to have an effect on the refractive error in the child (40).  In one study, the 
development of refraction was examined in premature infants at 6 months, 2.5 years, and 
10 years of age (40).  No significant difference was found between the various stages of 
retinopathy of prematurity and similar refraction was found at 6 months, 2.5 years, and 
10 years of age regardless of the stage of retinopathy of prematurity (40). 
One study, which examined the etiology of the high myopia associated with 
retinopathy of prematurity, concluded that it is pathophysiologically distinct from the 
high myopia seen in full-term patients.  In full-term patients, increasing myopia was 
associated with axial length,  with smaller contributions from increased lens thickness 
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and lens power.  However, in patients with retinopathy of prematurity, their lens-
thickness/anterior-chamber-depth ratio is almost 50% higher than full-term individuals, 
suggesting that the etiology of the high myopia in children with previous retinopathy of 
prematurity is due to a disturbance in anterior segment development (20). 
In one study, the visual function in very low birth weight children was compared 
with that of controls.  It was found that the visual function in very low birth weight 
children was much poorer than that of controls.  63% of VLBW children had reduced 
visual function, compared with 36% of controls.  The VLBW infants had a higher 
incidence of a variety of adverse visual outcomes:  increased need for corrective lenses, 
lower corrected visual acuity, a higher incidence of strabismus, and poor contrast 
sensitivity.  This study found that low birthweight, presence of an intraventricular 
hemorrhage, and a low 1-minute Apgar score predicted reduced visual function (21).  In 
addition, it was found that among the very low birth weight children poor visual function 
was predictive of lower IQ, and those children with reduced visual function were more 
likely to have significantly impaired motor skills.  Two possible explanations for the 
association between visual impairment and neurodevelopmental impairment were offered 
in the study.  One possible explanation is that both impairments are a result of 
neurological damage.  Alternatively, poor visual function may have an adverse affect on 
the development of motor and cognitive skills (21). 
Finally, in another study it was found that ocular morbidity was significantly 
higher among children who were of a very low birthweight.  They were found to have 
worse visual acuity, a higher incidence of strabismus, and a higher incidence of ROP.  
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Interestingly enough, a history of seizures in the perinatal period was correlated very 
highly with poor visual acuity (22). 
As retinopathy of prematurity is thought to have enormous effects on both 
cognitive and visual function persisting at least until childhood, we believed that being 
able to structurally examine the changes that occur in the brain through magnetic 
resonance imaging (MRI) would be especially enlightening.  In the past there have been 
studied performed which have looked at regional brain volumes in premature infant, but 
to our knowledge ours is the first study to look at the brain volumes in children who had 
retinopathy of prematurity.   
In one of the first quantitative MRI studies of long-term outcome of regional brain 
volumes in preterm infants it was found that regional cortical volumes in preterm 
children were significantly smaller than that of controls.  This difference was most 
significant in the sensorimotor regions, but also occurred in the premotor, midtemporal, 
parieto-occipital, and subgenual cortices.  Subcortical gray matter in the basal ganglia, 
white matter in the posterior corpus callosum, and cortical grey matter in the amygdala 
and hippocampus were also reduced.  The regional volumes were correlated significantly 
with gestational age at birth, 5-minute Apgar scores, and IHV within 6 hours of birth 
(23).  In addition, it was found that full-scale, verbal, and performance IQ scores were 
associated positively with regional volumes, and most strongly and consistently with 
volumes of sensorimotor and midtemporal brain regions (23).  This study found that 
preterm birth itself is associated with regionally specific, reductions in brain volume 
persisting into childhood, and that these structural changes are associated with a poorer 




The Randomized Indomethacin IVH Prevention Trial was conducted at Women 
and Infants' Hospital, Providence, RI; Maine Medical Center, Portland; and Yale New 
Haven Hospital, New Haven, Conn.  The protocols were reviewed and approved by the 
institutional review boards of each institution. Informed consent was obtained from all 
parents and children. 
Between September 5, 1989, and August 31, 1992, 505 infants weighing 600 to 
1250 g at birth were admitted within 6 hours of birth to 2 parallel randomized, 
prospective, low-dose indomethacin IVH prevention trials (24,25).  All infants were 
examined using cranial echoencephalography (ECHO) between 5 and 11 hours after 
birth.  Of the 505 enrolled infants, 431 had normal ECHO studies and were considered 
early IVH negative.  Seventy-four infants had ECHO evidence for IVH at this time; these 
were called early IVH positive. 
Subsequent scans were performed 24 and 48 hours after the first scan; 4, 5, 7, 14, 
and 21 days after birth; and at 40 weeks' postmenstrual age.  Scans were interpreted by 
the institutional radiologist and independently verified by a central radiologist.  In cases 
of disagreement, data were reexamined by all participating radiologists and a consensus 
was reached. 
Radiologic assessment was performed without prior knowledge of the infant's 
clinical condition. The grading system for hemorrhages was as follows (24,25) grade 1 
(blood in the germinal matrix regions); grade 2 (blood within the lateral ventricular 
system without ventricular dilation); grade 3 (blood within and distending the lateral 
ventricles); and grade 4 (blood within the ventricular system and parenchymal 
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involvement).  Ventriculomegaly was assessed at 40 weeks' postmenstrual age (or if not 
available 21 days after birth).  Moderate and severe ventriculomegaly were defined as 
measurements of 1.0 to 1.5 cm and more than 1.5 cm, respectively, at the midbody of the 
lateral ventricle on sagittal scan.  Studies were also evaluated for focal echolucencies.  
All cases showing focal echolucencies had cystic areas consistent with periventricular 
leukomalacia (PVL) on the ultrasound performed at 40 weeks' postmenstrual age.  A 
study infant was defined as having significant central nervous system (CNS) injury if 
he/she had 1 or more of the following 3 ultrasound findings: grade 4 IVH at any time 
following the first scan at 5 to 11 hours; PVL at term; or ventriculomegaly at term. 
All infants underwent gestational age assessment using a modification of the 
Ballard scale (26).  Prenatal, perinatal, and neonatal data were obtained by maternal 
interviews and review of the maternal and neonatal charts.  Randomization to low-dose 
indomethacin was categorized as present/absent.  An infant was diagnosed with 
bronchopulmonary dysplasia (BPD) if he/she both required oxygen supplementation and 
had an abnormal chest radiograph at 28 days of life (27); BPD was categorized as 
present/absent. 
At 12 years of chronologic age, children were evaluated with the PPVT-R and the 
Wechsler Intelligence Scale for Children–Third Edition (WISC-III) (28), a norm-
referenced instrument for assessing the intellectual function of children aged 6 years 0 
months through 16 years 11 months.  The WISC-III also provides 3 IQ scores: PIQ, VIQ, 
and full-scale IQ, with a mean (SD) of 100 (15). 
Serial neurodevelopmental follow-up evaluations were performed on all study 
participants.  At 12 years of corrected age (ie, months past the obstetric due date), each 
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child was tested with the Peabody Picture Vocabulary Test–Revised (PPVT-R) (30), an 
age-normed test that requires no verbal responses from the child and measures receptive 
vocabulary words of individuals aged 2½ years through adulthood.  Raw scores are 
converted to standard scores with a mean (SD) of 100 (15) points.  The PPVT-R does not 
require a motor response and is thus an excellent instrument for use with children with 
motor disabilities (31). 
The Peabody Individual Achievement Test-Revised (PIAT-R) (32) is a battery of 
academic achievement tests for children ages 5 years 0 months to 18 years 11 months. 
The reading recognition, mathematics, and spelling subtests were administered. 
Demographic questionnaires, which included information on household composition, 
languages spoken in the home, educational level of the biological or adoptive/foster 
parent, school placement of the child, resource utilization, and need for medications, were 
administered to the parent/caregiver. 
A standard neurologic examination was performed by the pediatric 
neurologist/developmental pediatrician at each site.  The neurologic examination included 
determinations of height, weight, and occipitofrontal head circumference, assessment of 
visual field testing, pupillary function, eye movements, and facial strength.  Tone, 
strength, reflexes, and cerebellar function were determined.  A determination of normal, 
suspect, or abnormal neurologic status was made.  Abnormal or suspect assessments were 
secondarily assessed for the presence of microcephaly, spastic diplegia, hemiplegia, or 
quadriplegia. 
Demographic information was obtained from the primary caregivers.  Maternal 
education was categorized as less than high school or high school graduate or higher. 
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Residence in a 2-parent household at 96 months of CA was coded yes/no, and parents 
were defined as birth mother, adoptive mother, stepmother, and/or birth father, adoptive 
father, and stepfather.  Early intervention services including occupational therapy, 
physical therapy, speech, and/or language therapy were obtained from parent/caregiver 
report.  A child was considered positive for these special services if he/she received 1 or 
more services at 36 months of CA, consistent with previous studies (33,34). 
Study participants were divided into ROP (-), ROP grade 1-2, and ROP grade 3-4 
to evaluate scores.  The PPVT-R scores were selected as our primary outcome measure 
prior to statistical analysis, because the same test was used at all 4 measurements.  The IQ 
scores were a secondary outcome measure.  Finally, z scores were calculated for the full-
scale IQ, VIQ, and PIQ scores for each child at each age. 
To understand important biological or environmental factors that may be 
associated with testing scores, factors reported to be associated with the occurrence of 
retinopathy of prematurity were evaluated:  Birth weight (g), gestational age (wk), male 
sex, 1 and 5 minute Apgar scores, administration of antenatal steroids, randomization to 
indomethacin, randomization to indomethacin and steroids, preeclampsia +/- eclampsia, 
IVH (both within first 6 postnatal hrs and at post-natal day 5), Grade 3-4 IVH post-natal 
day 5, administration of pressor drugs, administration of caffeine, aminionitis, BPD, 
Assisted ventilation for >12hrs, RDS, apnea, pneumothoraces, hypoglycemia, 
hyperglycemia, PVL, ventriculomegalay, and seizures at discharge. 
Categorical data with no expectation of a linear trend among groups (e.g., sex) 
were analyzed using Fisher exact test.  Categorical data with an a priori expectation of a 
linear trend among groups were analyzed by the [chi]2 test for linear trend.  The 2-sample 
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Wilcoxon rank sum test was used for between-group comparisons of continuous data. 
Because PPVT-R scores were not always normally distributed, summary statistics for this 
factor were reported using medians and ranges. 
Hierarchical multivariate regression models were used to examine the effect of 
several factors simultaneously.  All significant higher-order interaction terms required 
inclusion of all lower order (i.e., main effect) factors in the model.  The first model 
evaluated the main effects only to determine which factors played an independent role in 
predicting the occurrence of ROP.  Using this reduced set of important factors, a second 
model was developed in which the main effects and the interaction of these factors with 
one another were explored.  A significant interaction implies that the effect of one factor 
on PPVT-R scores varies significantly according to the level of the other factor.  All 
statistical analyses were performed using SAS software version 8.2 (SAS Institute Inc, 
Cary, NC). All P values are 2-sided and statistical significance was assigned at P<.05.  












As shown in Table 1, there was a significant difference in the gestational ages, 
birth weights, 1-minute and 5-minute Apgar scores, IVH at 5 days, pressor drugs, 
amnionitis, bronchopulmonary dysplasia, assisted ventilation for >12hrs, respiratory 
distress syndrome, and periventricular leukomalacia between the ROP (-) (n=163), ROP 
(1,2) (n=137), and ROP (3,4) (n=23). 
As show in Table 1, there were no significant differences in male sex, 
administration of antenatal steroids, administration of indomethacin, administration of 
indomethacin and steroids, preeclampsia +/or eclampsia, IVH (within first 6 postnatal 
hrs), grade 3-4 IVH post-natal day 5, caffeine, apnea, pneumothoraces, hypoglycemia, 
hyperglycemia, ventriculomegaly, and seizures at discharge between the ROP (-) 




Characteristics  ROP (-) ROP (1,2) ROP (3,4) p-value 
   (n=163) (n=137) (n=23)    
 
Birth weight, g 1035.2 864.6 841.7 <.0001  
Gestational age, wk 28.5 27.1 27.0 <.0001  
Male 82(50.31) 81(59.12) 15(65.22) 0.0823  
1-Minute Apgar score, median  4.9 3.9 3.4 0.0003  
5-Minute Apgar score, median 6.9 6.2 6.2 0.0012 
Antenatal Steroids 59(36.20) 47(34.31) 8(34.78) 0.8009 
Indomethacin 73(44.79) 73(53.28) 9(39.13) 0.8317 
Indomethacin and Steroids 27(16.56) 26(18.98) 4(17.39) 0.7560 
 29
Preeclampsia +/or Eclampsia 21(12.88) 7(5.11) 3(13.04) 0.3436 
IVH (within first 6 postnatal hrs) 16(9.82) 22(16.06) 5(21.74) 0.0515 
Any IVH at post-natal day 5 31(19.02) 42(30.66) 11(47.83) .0008 
Grade 3-4 IVH post-natal day 5 5(3.07) 4(2.92) 3(13.04) 0.0593 
Pressor Drugs 13(7.98) 16(11.68) 9(39.13) <.0001 
Caffeine 100(61.35) 78(56.93) 13(59.09) 0.6158 
Amnionitis 16(9.88) 25(18.66) 6(26.09) 0.0105 
Bronchopulmonary dysplasia 51(31.29) 90(66.18) 21(91.30) <.0001 
Assisted Ventilation for >12hrs 119(73.01) 124(90.51) 22(95.65) 0.0001  
Respiratory Distress Syndrome 128(79.01) 119(86.86) 23(100.00) 0.0044 
Apnea 72(44.17) 55(40.44) 9(39.13) 0.5180 
Pneumothoraces 4(2.47) 5(3.65) 2(8.70) 0.1385 
Hypoglycemia 26(15.95) 25(18.25) 3(13.04) 0.9544 
Hyperglycemic 89(54.60) 88(64.23) 13(56.52) 0.3905 
Periventricular leukomalacia 6(3.70) 5(3.68) 4(17.39) 0.0187 
Ventriculomegaly  9(5.56) 8(5.88) 2(8.70) 0.5935  




As shown in Table 2, the was a significant difference in the incidence of 
corrective lenses at 12 years of age, services for blind at 12 years of age, normal vision at 
12 years of age, decreased vision at 12 years of age, absent vision at 12 years of age, full 
and equal eye movements at 12 years of age, and abnormal eye movements at 12 years of 





Characteristics  ROP (-) ROP (1,2) ROP (3,4) p-value  
   (n=163) (n=137) (n=23)  
 
Corrective Lenses @12 31/102 (30.39) 41/106 (38.68) 15/2 (171.43) 0.0007 
Services for Blind@12 1/102 (0.98) 0 7/21 (33.33) <.0001 
Normal vision at 12 56/93 (60.22) 46/90 (51.11) 2/20 (10) <.0001 
Decreased vision at 12 36/93 (38.71) 44/90 (48.89) 16/20 (80) <.0001 
Absent vision at 12 1/93 (1.08) 0 2/20 (10) <.0001 
Full and equal eye movements 39(97.5) 43(95.56) 5(55.56) 0.0020 
Abnormal Eye Movements 1/40(2.5) 2/45(4.4) 4/9(44.4) 0.0020 
 
 
Using the Cox regression model, multivariate analyses were performed to identify 
those perinatal characteristics shown in Table 1 that were significantly associated with 
retinopathy of prematurity.  As shown in Table 3, we found that birthweight (P = .0330), 
periventricular leukomalacia (P = <.0001), indomethacin (P = .0363), indomethacin and 
Steroids (P = .003), and less than high school (P = .0008) were independent and 
significant predictors. 
 
Table 3: Multivariate Analysis   
 
Variable Parameter Standard Type II SS F Value  Pr>F 
 Estimate Error
 
ROP, Stage 3-4 -11.48 4.01  2214.64 8.18  .0045 
Birth-weight .0117 .0055 1241.82 4.59  .0330 
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Periventricular -21.55 4.69  5714.93 21.10  <.0001  
   Leukomalacia 
Indomethacin -4.58 2.178 1197.44 4.42  .0363 
Indomethacin and 10.44 2.83  3694.99 13.64  .003 
   Steroids 
Less than high school -10.29 3.03  3106.27 11.47  .0008 
 
Cognitive test scores for the 3 study groups at 12 years are shown in Table 4. 
Children in both the ROP (-) and ROP 1,2 had significantly higher verbal IQ, 
performance IQ, full-scale IQ, and PPVT standard scores for reading recognition, reading 
comprehension, and math than those in ROP 3,4. 
 
 
Table 4:  Cognitive and Educational Test Results at 12 Years of Age 
 
Characteristics ROP (-) ROP (1,2)  ROP (3.4) p-value  
 (n=163)  (n=137)  (n=23)    
 
N 163 136 23 <.0001 
Verbal IQ 91.2 ±18.5 90.6±19.8 80.7±23.4 <.0001 
Performance IQ 89.2 ±17.0 84.9±17.7 69.3±19.9 <.0001 
Full-Scale IQ 89.2 ±18 86.8±18.2 72.6±23.4 <.0001 
PPVT 92.9 ±23.4 92.5±26.7 74.3±35.1 <.0001 
Full scale <70 17(5.38) 22(6.96) 10(3.16) <.0001 
Verbal scale <70 16(4.98) 17(5.30) 7(2.18) 0.0093 
Performance <70 18(5.64) 26(8.15) 11(3.45) <.0001 
PPVT-R <70 16(5.05) 20(6.31) 9(2.84) 0.0004 
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 Our brain volume data can be found in Table 5.  In our study, we found that the 
whole brain volumes were significantly less for children with any grade of ROP (p = 
0.02), occipital white matter volumes tended to be less for the same study subjects (p = 
0.08) and both total occipital brain volumes and occipital white matter volumes were 
significantly correlated with Beery VMI scores (r=0.610, p = 0.009 and r = 0.652, p 
=0.005, respectively).   
 
Table 5:  MRI findings at 12 years of age 
 
Characteristics  ROP (-)  ROP (+)  p-value  
  (n=23)  (n=17)    
 
Total brain volume  1420.8 ±82.3  1343.5 ±136.0  .022 
 
Occipital lobe, white  61.36 ±9.45 55.22 ±11.07  .078 
 
Occipital lobe, gray  68.277 ±8.63 64.86 ±9.63  .976 
 
Occipital lobe, total  129.63 ±12.33 120.08 ±17.48  .391 
 






Retinopathy of prematurity remains the leading cause of childhood blindness in 
the United States.  It has been estimated that anywhere from 20% to 68% of premature 
infants may develop retinopathy of prematurity (6,41) and up to 8% of cases may 
progress to blindness.  In our study, we found the incidence of any stage retinopathy of 
prematurity to be 160/323 = 49.5%.  The reasons for the differing incidences in the 
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studies is unclear, but could perhaps related to the difference in the diagnosis of 
retinopathy of prematurity by the various ophthalmologists, and differing care in the 
neonatal intensive care unit in the various sites. 
The various risk factors for retinopathy of prematurity have been studied in many 
previous studies.  There has been a consensus for many of the risk factors of retinopathy 
of prematurity, including a decreasing gestational age, decreasing birthweight, and 
increasing apneic episodes.  However many other risk factors remain controversial, 
including race, sex, and indomethacin use among others.  We have sought to study both 
the agreed upon risk factors, in order to add to the existing literature, as well as the 
controversial risk factors in hopes of being able to further elucidate the many risk factors 
of retinopathy of prematurity. 
Gestational age is a well known risk factor for retinopathy of prematurity.  Many 
previous studies have found that infants who developed retinopathy of prematurity had a 
lower gestational age (6, 7, 38).  Our study, not surprisingly showed that retinopathy of 
prematurity is associated with a lower gestational age.  However, we found that an 
increase in the stage of the retinopathy of prematurity was in fact not associated with a 
lower gestational age.  The average gestational age found in our study for ROP (-) was 
28.5 week, for ROP (1,2) was 27.1, and ROP (3,4) was 27.0 weeks.  Therefore a lower 
gestational age may be associated with an increased incidence of retinopathy of 
prematurity, but not necessarily with an increase in the severity of the retinopathy of 
prematurity. 
The birthweight of the infant is another well known risk factor for the occurrence 
of retinopathy of prematurity.  In previous studies it has been found that the birthweight 
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for those infants with retinopathy of prematurity is lower than that of controls (6, 7, 38).  
In our study, we too found that a decreased birth weight was correlated not only with an 
increased incidence of retinopathy of prematurity, but also with an increase in severity of 
the retinopathy of prematurity.  We found that the ROP (-) infants had an average birth 
weight of 1035.2 g, the ROP (1,2) infants had an average birthweight of 864.6 g, while 
the ROP (3,4) infants had an average birthweight of  841.7 g. 
However important birthweight may be a factor in retinopathy of prematurity, it is 
not the only factor involved.  Between the years 1989 and 1998 despite a decrease in the 
mean gestational age and birthweight of premature infants, there was also a decrease in 
the incidence of retinopathy of prematurity (1).  This reduced incidence of ROP is 
possibly attributed to improvements in ventilation techniques and the overall care of the 
neonate, in particular the use of prenatal steroids and surfactant (1).  Thus the incidence 
of retinopathy of prematurity in the infant is a complicated interaction of many variables. 
As hypoxic injury is the original stimulus for retinopathy of prematurity, apnea is 
thought to be a risk factor for the occurrence of retinopathy of prematurity.  In previous 
studies it has been found that an infant being on ventilator care for ≥ 48 hours has been a 
risk factor for retinopathy of prematurity and that frequent apneic attacks increased the 
progression of pre-threshold ROP to threshold ROP (6).  In addition, another study found 
that the higher number of days on oxygen/ventilator and more days in the ICU were also 
risk factors for the incidence of retinopathy of prematurity (7).  In our study, assisted 
ventilation for >12hrs was found to be significantly correlated with the incidence of 
retinopathy of prematurity (p = .0001).  In addition, respiratory distress syndrome was 
also correlated with an increased incidence of retinopathy of prematurity (p = 0.0044).  
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However, apnea itself was not correlated with an increased incidence of retinopathy of 
prematurity in our study (p = .5180). 
The role of indomethacin in the prevention of retinopathy of prematurity has not 
been fully understood in the past.  Indomethacin is a nonsteroidal anti-inflammatory 
agent which acts by inhibiting prostaglandin production.  Indomethacin is thought to 
improve retinopathy during periods of hyperoxia injury, because of its effect on retinal 
neovascularization (by inhibiting prostaglandin production).  One study performed in the 
1980’s found that indomethacin did not impact the incidence of retinopathy of 
prematurity (44).  However a study performed in 1999, which looked at a mouse model, 
demonstrated an improvement in oxygen induced retinopathy with indomethacin 
treatment (8).  In addition, one study performed in 2003 examined the effect of ibuprofen 
(a nonsteroidal anti-inflammatory agent similar to indomethacin) on oxygen-induced 
retinopathy in a mouse model and also demonstrated an improvement in oxygen induced 
retinopathy (45).  In addition, post-natal steroid use has been found to be a risk factor in 
retinopathy of prematurity.  In one study, of 21 factors were examined, and only steroid 
use for lung disease was associated with the need for cryotherapy (11).  However, our 
study did not show a significant statistical difference in the incidence of retinopathy of 
prematurity in both the indomethacin group, as well as the indomethacin + steroids group 
(P = .8317 and P = .7560l, respectively). 
Two previous studies have reported that twice the number of male infants are 
affected with retinopathy of prematurity (53, 54).  In one study it was suggested that there 
was an increased risk of cryotherapy in boys (12).  In our study, we too found an 
increased incidence of retinopathy of prematurity in male infants.  While ROP (-) was 
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approximately split half and half (50.31%), 59.12% of stage 1,2 ROP infants were male 
and 65.22% of stage 3,4 ROP infants were males. 
In previous studies, it was found that maternal pre-eclampsia may lead to a more 
favorable outcome for premature infants, perhaps due to the fact that hypertension causes 
intrauterine stress and subsequent maturation of the eyes (12).  However, in our study we 
found no statistically significant difference in the incidence of any stage ROP with the 
incidence preeclampsia +/- eclampsia in the mother. 
In previous studies it has been found that an increased risk of retinopathy of 
prematurity was correlated with each 10 mg/dl increase of mean glucose (46).  However, 
in our study we did not find any statistically significant difference in the infants with 
either hypoglycemia, or hyperglycemia (p values of .9544 and .3905 respectively). 
In one study it was found that a higher percentage of the dopamine treated infants 
reached prethreshold retinopathy of prematurity (67% versus 13%), as well as threshold 
retinopathy of prematurity (39% versus 4%) (12).  An additional study found an 
increased risk of retinopathy of prematurity was correlated with a history of dopamine 
infusion (52).   In our study we found a statistically significant difference (p<.0001) in 
those infants treated with pressor drugs versus those of controls and the incidence of 
retinopathy of prematurity stage 3,4. 
 It has been found that an increased risk of retinopathy of prematurity was 
correlated with an intraventricular hemorrhage. (52).  In our study we found that 
intraventricular hemorrhage was indeed correlated with retinopathy of prematurity.  We 
looked first at intraventricular hemorrhage occurring within the first 6 postnatal hours, 
and found it to be correlated with an increased incidence of retinopathy of prematurity  (p 
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= 0.051).  In addition, we looked at intraventricular hemorrhage occurring at post-natal 
day 5, and found that it too was correlated with an increased incidence of retinopathy of 
prematurity (p = .0008).  Finally, we looked at grade 3-4 IVH at post-natal day 5, and 
found that it also was correlated with retinopathy of prematurity (p = 0.0593). 
 In our multivariate analyses we found that birthweight (P = .0330), periventricular 
leukomalacia (P = <.0001), indomethacin (P = .0363), indomethacin and steroids (P = 
.003), and less than high school (P = .0008) were independent and significant predictors. 
It has been noted that two percent of the prematurely born children are visually 
impaired (<20/60) (17).  The visual function in very low birth weight children has been 
found to be much poorer than that of controls (21).  In addition, the very low birth weight 
infants have a higher incidence of a variety of adverse visual outcomes including worse 
visual acuity and a higher incidence of strabismus (19,21).  In our study, we sought to 
examine the difference in incidence of various visual outcomes in premature infants with 
retinopathy of prematurity using premature infants without ROP as the controls.  We 
found that there was a significantly higher incidence in services for blind at 12 years of 
age (P = <.0001), decreased vision at 12 years of age (P = <.0001), absent vision at 12 
years of age (P = <.0001), and abnormal eye movements at 12 years of age (P = .002), in 
the ROP (3,4) group. 
The incidence of refractive errors in premature infants has been found to be 4 
times more common in 10-year olds when compared with full-term controls (19).  
Interestingly enough, the high myopia associated with ROP is thought to be 
pathophysiologically distinct from the high myopia in full-term patients (20).  Although 
the incidence of refractive error in premature infants with retinopathy of prematurity 
 38
itself is higher than controls, in a previous study, the stage of retinopathy of prematurity 
did not have an effect on the refractive error (40).  In our study we found an increased 
incidence of corrective lenses in children with a previous history of retinopathy of 
prematurity (P = .0007).  In our study, we found a statistically significant difference in 
the incidence of corrective lenses in the ROP stage (3,4) infants when compared to ROP 
(-), as well as that of ROP stage (1,2), which differs from the findings of the previous 
study (40).   
Although retinopathy of prematurity has become a relatively common finding in 
the era of extremely premature infants, there is a scarcity of studies performed to look at 
the correlation of retinopathy of prematurity and cognitive function in older children who 
previously had retinopathy of prematurity.  In one study severe retinopathy of 
prematurity showed the strongest association with 18-month outcome (15).  In another 
study it was found that among extremely premature infants (less than 28 weeks, with 
normal neonatal cranial ultrasounds), serum bilirubin and retinopathy of prematurity were 
associated with developmental impairment at 5 years of age.  Interestingly enough in this 
study, gestational age and birth weight themselves were not associated with a poorer 
developmental outcome (13).  
In the past, in the CRYO-ROP Multicenter study, the educational status and 
special education services among children who had threshold retinopathy of prematurity 
were examined at 8 years of age.  Threshold retinopathy of prematurity was associated 
with higher rates of developmental, educational, and social challenges in middle 
childhood .  In addition, of the 8-year-old children with a history of threshold ROP, there 
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were significant developmental, educational, and social skill differences between those 
who had favorable versus unfavorable visual status in the better eye (18).    
In a different study it as found that VLBW children with reduced visual function 
were more likely to have significant impairment of motor skills, and poor visual function 
was predictive of lower IQ (21).  In one of the first studies in which health related quality 
of life was looked at in formerly premature children, it was found that threshold ROP was 
associated with functional limitations in health attributes, as well as in reductions in 
health related quality of life scores at 10 years of age.  In addition, like many previous 
studies, those children who had poor visual outcome, had a worse health related quality 
of life score than those with better sight (14). 
In this study we sought to examine the hypothesis that retinopathy of prematurity 
would result in decreased cognitive ability at 12 years of age when compared to that of 
premature infants without retinopathy of prematurity.  We believe that this is the oldest 
cohort in which the correlation of retinopathy of prematurity and IQ has been examined. 
We looked at performance, verbal and full scale IQ for 12 year old who were previously 
ROP (-), ROP stage 1,2, and ROP stage 3,4.  In our study, children in both the ROP (-), 
and ROP stage 1,2 had significantly higher verbal IQ, performance IQ, full-scale IQ, and 
PPVT standard scores for reading recognition, reading comprehension, and math than 
those with previous ROP stage 3,4.  There are several possible explanations for this 
correlation.  The first of which is that children with previous retinopathy of prematurity 
have a higher incidence of impaired vision, and as shown in previous studies impaired 
vision is correlated with decreased cognitive ability (18,21).  Another possible 
explanation is that the visual deprivement that occurs during infancy from the retinopathy 
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of prematurity has lasting effects on the brain itself.  Finally, we have shown that the 
infants with retinopathy of prematurity are sicker infants, with lower birthweights and 
lower gestational ages, so it is possible that the lower IQ’s are a result of neurological 
damage unrelated to the ROP. 
In the first quantitative MRI study of long-term outcome of regional brain 
volumes in preterm infants it was found that regional cortical volumes in preterm 
children were significantly smaller than controls and that the regional volumes were 
correlated significantly with gestational age at birth, 5-minute Apgar scores, and IHV 
within 6 hours of birth.  In addition, it was found that preterm birth was associated with 
regionally specific, long-term reductions in brain volume, and that these morphological 
abnormalities were in turn associated with poorer cognitive outcome (23).  
To our knowledge, there have been no prior neuroimaging studies of children 
with retinopathy of prematurity that employ statistical analysis.  In our study, we found 
that the whole brain volumes were significantly less for children with any grade of ROP 
(p = 0.02), occipital white matter volumes tended to be less for the same study subjects (p 
= 0.08) and both total occipital brain volumes and occipital white matter volumes were 
significantly correlated with Beery VMI scores (r=0.610, p = 0.009 and r = 0.652, p 
=0.005, respectively).  This is an extremely interesting finding, as it is all stages of ROP 
which showed a significant difference in brain volume, both whole and occipital white 
matter volume, regardless of the visual outcome of the infant.  As most stage 1,2 
retinopathy of prematurity regresses on its own, it is especially interesting to note there is 
a difference in the occipital lobe brain volumes in all stages of retinopathy of prematurity, 
including that of stage 1,2 retinopathy of prematurity. 
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One possible explanation for this difference in brain and occipital lobe volume is 
that the infants with retinopathy of prematurity are sicker infants, with a lower 
birthweight and gestational age.  However, we need to explain the difference in occipital 
lobe volumes that exists between children who previously had retinopathy of prematurity, 
and those who have not, when no difference exists between these two groups in other 
areas of the brain, including the cerebellum.  As the cerebellum is known to be extremely 
sensitive to hypoxia, the finding that there is no difference in the cerebellar volumes 
between these two groups leads us to conclude that the difference in brain volumes is a 
result of the difference in occipital lobe volumes, and not from hypoxia.  Moreover, we 
believe that it is the visual deprivation that occurs because of the retinopathy of 
prematurity (either during infancy, or persisting later into childhood in more severe 
stages), which results in this difference in the occipital lobe volumes. 
The human visual system is an important example of neuronal plasticity during 
development.  In humans, visual input is required in order for the visual system in the 
brain to reach its full development .  For example, binocular vision is extremely sensitive 
to visual experiences during the first months of life.  If the vision of one or both eyes is 
impaired through cataracts, high refractive error, or a deviated eye during infancy a 
permanent reduction in the quality of vision may result (43).  It has been postulated in 
previous studies that the abnormal visual experience during critical developmental 
periods and the resulting visual deficits are associated with structural changes in visual 
portions of the brain (43).  In the past these hypothesis have been looked at in children 
with amblyopia or visual deprivation due to cataracts or high refractive error.  However, 
in this study we believe that we are able to demonstrate that the visual deprivation caused 
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by the existence of any stage retinopathy of prematurity in the infant during a critical 
development period, causes structural changes in the brain which persist at least through 
childhood.  It is extremely interesting that structural changes can be seen in the brain at 





We believe that we have added to the already abundant body of knowledge of 
various risk factors for retinopathy of prematurity.  We have also looked at the cognitive 
sequelae in the oldest subset of children with previous retinopathy of prematurity, and 
have shown that children with previous stage 3,4 retinopathy of prematurity have lower 
performance on cognitive, language and visual motor integration scores at age 12 years of 
age.  We are the first study to look specifically at the brain volumes of children with a 
previous history of retinopathy of prematurity, compared to that of premature controls.  
We believe that the results of this study are very important as they may further elucidate 
the consequence that retinopathy of prematurity may have on the developing brain.  This 
will be invaluable to further understanding the mechanism of the developing visual 
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